Uterine Myoma: Optimization of Management and Immunomodulating Therapy

Narzulloeva N.S.

doi:10.51699/ijhsms.v1i4.232

Uterine Myoma: Optimization of Management and Immunomodulating Therapy

Authors

Narzulloeva N.S. Bukhara State Medical Institute

DOI:

https://doi.org/10.51699/ijhsms.v1i4.232

Keywords:

uterine fibroids, humoral immune response

Abstract

This article presents the results of studies of 37 women with uterine fibroids. Studies show the positive efficacy of T-life, used as an immunocorrective treatment for uterine fibroids.

Downloads

Download data is not yet available.

Downloads

View article

Published

2022-10-28

How to Cite

Narzulloeva N.S. (2022). Uterine Myoma: Optimization of Management and Immunomodulating Therapy. INTERNATIONAL JOURNAL OF HEALTH SYSTEMS AND MEDICAL SCIENCES, 1(4), 284–289. https://doi.org/10.51699/ijhsms.v1i4.232